CODON CAPITAL
Codon Capital is a venture capital firm that brings entrepreneurs and researchers to discover strategies for translating innovation into products and startup companies. It focuses on two biology disciplines, Therapeutics and Synthetic Biology, each with unique investment benefits. Together, they represent the new biology design revolution, opportunities that will define healthcare, and agriculture. Founded in 2013 by Karl Handelsman, Codon Capital is headquartered in San Francisco, California.
CODON CAPITAL
Industry:
Angel Investment Biotechnology Impact Investing Venture Capital
Founded:
2013-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager Global Site Tag ReCAPTCHA AJAX Libraries API Google Analytics 4 Google Analytics Classic
Similar Organizations
Alumni Ventures
Alumni Ventures Group provides diversified venture portfolios to individual investors who previously haven't had access to VC.
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-11 | Ansa Biotechnologies | Codon Capital investment in Series A - Ansa Biotechnologies | 68 M USD |
| 2020-05-07 | Good Therapeutics | Codon Capital investment in Series A - Good Therapeutics | 11 M USD |
| 2020-04-30 | Pivot Bio | Codon Capital investment in Series C - Pivot Bio | 100 M USD |